sameAs
Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trialsEfficacy and tolerability of second-generation antidepressants in social anxiety disorderLong-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designsThe use of lorazepam TID for chronic insomniaPharmacology and pharmacokinetics of milnacipranFaster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group studyMianserin or placebo as adjuncts to typical antipsychotics in resistant schizophreniaAcetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depressionShortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label studyA tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjectsSevere depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatineThe effects of sertraline on psychopathic traitsTreatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experienceZopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxietySocial phobia: long-term treatment outcome and prediction of response--a moclobemide studyMoclobemide for anxiety disorders: a focus on moclobemide for panic disorderEffects of mianserin on negative symptoms in schizophreniaComparison of performance of healthy volunteers given prazepam alone or combined with ethanol. Relation to drug plasma concentrationsRIMA--a new concept in the treatment of depression with moclobemideMoclobemide--placebo-controlled trialsThe role of moclobemide in endogenous depression: a survey of recent dataMoclobemide versus imipramine in depressed out-patients: a double-blind multi-centre studyA comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunctionAn update of recent moclobemide interaction dataThe effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjectsAntidepressant interactions with warfarinA clinical and neurophysiological evaluation of clotiazepam, a new thienodiazepine derivativeA comparison of the pharmacological properties of the novel tricyclic antidepressant lofepramine with its major metabolite, desipramine: a reviewA placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophreniaIntravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawalSafety of antidepressantsMoclobemide: a paradigm of research in clinical psychopharmacologyMoclobemide in the treatment of social phobiaPreclinical pharmacology of milnacipranComparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial resultsMilnacipran and selective serotonin reuptake inhibitors in major depressionThe effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteersPositive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoatesThe calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patientsA preliminary study of the effects of flosequinan on psychomotor function in healthy volunteers
P1433
Q21094927-f39695e4-4884-2b37-6db8-b8dc6896f991Q24656009-ABE9D1D2-FCCF-406D-ABB0-3E34B981BC35Q28085407-98E5F266-A263-4D10-892C-79B195E13891Q28142553-90F8485E-5550-4BB5-BD9C-7B70BD9D2739Q28205848-35B86517-C949-48E7-BF82-A111B74D96D3Q28205872-46723662-EB36-46EF-A764-A1B6AC72C2B7Q28206577-903830C7-756D-462A-B107-6D95937AE92DQ28217850-2E07B8FA-4834-4FED-A356-5D19076B35CAQ28217866-17DAA0D6-03B8-45A9-840B-3669DFC289B5Q28235923-0E11C46D-03EE-43B9-98BD-D73EEA5D4027Q28240140-DF787406-F593-4518-972E-C20B493068C4Q28247724-9E4DFB4B-E011-4062-9BAF-0BA03AFA1824Q28256403-A8730AA9-AFA5-4020-B730-F040F52DE05AQ28258789-4E606DEB-371E-4385-B304-CCCBAF404BEEQ28261918-BF6238B2-6F7A-4B6D-B23F-37A8694F3EF9Q28261928-88B46562-DB65-42CD-85D3-EF0F80E9A3F2Q28262803-F7CB76FF-B5DA-4BEA-8ADB-4EA258D1F0BEQ28262968-F0F9339E-A201-4A24-AF31-533E570413D7Q28267892-3E37FFE6-B20D-41F9-8F29-C2E611B584D7Q28267902-2B844DEB-7535-4A87-AD94-00ED1D2A4A61Q28267913-59F85AC4-E17A-4596-86BD-46934C9950D3Q28267922-F7924BE5-87A7-4046-857A-BE4B78D32C39Q28267932-76DAD622-50F1-4EEF-ACFF-40E431EBDDD0Q28267943-70E1629E-C9A9-4CD8-AF06-576196491602Q28268176-3431AB66-2B95-4C99-A550-9A77FD5EC93DQ28276855-CAC47666-D130-4435-9285-F36B7EB9D08AQ28282998-5B1054FD-9A76-459E-BBA6-2806197ACA15Q28283312-028161F7-9477-40EC-A97F-0299B8939275Q28283422-9209841A-272F-4EB7-93F3-F80C4C68A195Q28289596-8950723B-0277-4037-B31F-4890C9611B42Q28294195-00AE9858-3B29-46A5-B96F-EFC0D68D5FF2Q28297059-A6389FF3-5862-49A5-A05F-8D83C0CEDDF2Q28297071-6E3147C8-C3E7-402F-82D7-3103185062FCQ28297082-8A3428AC-728F-4A31-BBBC-040A551854F4Q28297092-D9738735-AAC8-496F-A652-92902FC2C7DDQ28297103-E337EE72-3C5F-4C42-A0E3-0F65E258158CQ28305055-212E6D63-77E7-41CE-BA81-F84CA8676E4BQ28318152-E7446D91-304B-434F-8423-C6B7EA169F45Q28318156-7C5257D7-216B-4C05-AB47-05CF7AC4FC26Q28325755-24159473-874A-4771-BF59-242FDC428E86
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
videnskabeligt tidsskrift
@da
vědecký časopis
@cs
wetenschappelijk tijdschrift van Wolters Kluwer
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
International Clinical Psychopharmacology
@ast
International Clinical Psychopharmacology
@da
International Clinical Psychopharmacology
@de
International Clinical Psychopharmacology
@en
International Clinical Psychopharmacology
@es
International Clinical Psychopharmacology
@fi
International Clinical Psychopharmacology
@fo
International Clinical Psychopharmacology
@fr
International Clinical Psychopharmacology
@is
International Clinical Psychopharmacology
@it
type
label
International Clinical Psychopharmacology
@ast
International Clinical Psychopharmacology
@da
International Clinical Psychopharmacology
@de
International Clinical Psychopharmacology
@en
International Clinical Psychopharmacology
@es
International Clinical Psychopharmacology
@fi
International Clinical Psychopharmacology
@fo
International Clinical Psychopharmacology
@fr
International Clinical Psychopharmacology
@is
International Clinical Psychopharmacology
@it
altLabel
Int Clin Psychopharmacol
@da
Int Clin Psychopharmacol
@de
Int Clin Psychopharmacol
@en
prefLabel
International Clinical Psychopharmacology
@ast
International Clinical Psychopharmacology
@da
International Clinical Psychopharmacology
@de
International Clinical Psychopharmacology
@en
International Clinical Psychopharmacology
@es
International Clinical Psychopharmacology
@fi
International Clinical Psychopharmacology
@fo
International Clinical Psychopharmacology
@fr
International Clinical Psychopharmacology
@is
International Clinical Psychopharmacology
@it
P243
P3181
P1055
P1058
P1156
P1159
P123
P1250
P1277
P1476
International Clinical Psychopharmacology
@en